Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion type Assertion NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_head.
- NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion description "[Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_provenance.
- NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion evidence source_evidence_literature NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_provenance.
- NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion SIO_000772 16230147 NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_provenance.
- NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion wasDerivedFrom befree-20150227 NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_provenance.
- NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_assertion wasGeneratedBy ECO_0000203 NP391025.RAZDLlPD9gA6tFo1Av21t1Qda4fQIlaSPrRqIyrguoHrg130_provenance.